<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Transl Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Transl Psychiatry</journal-id>
<journal-title-group>
<journal-title>Translational Psychiatry</journal-title>
</journal-title-group>
<issn pub-type="epub">2158-3188</issn>
<publisher>
<publisher-name>Nature Publishing Group UK</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29317598</article-id>
<article-id pub-id-type="pmc">5802446</article-id>
<article-id pub-id-type="publisher-id">58</article-id>
<article-id pub-id-type="doi">10.1038/s41398-017-0058-6</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Enriched expression of genes associated with autism spectrum disorders in human inhibitory neurons</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Ping</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Dejian</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lachman</surname>
<given-names>Herbert M.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4354-5337</contrib-id>
<name>
<surname>Zheng</surname>
<given-names>Deyou</given-names>
</name>
<address>
<email>deyou.zheng@einstein.yu.edu</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121791997</institution-id><institution-id institution-id-type="GRID">grid.251993.5</institution-id><institution>Department of Genetics, </institution><institution>Albert Einstein College of Medicine, </institution></institution-wrap>1300 Morris Park Ave., Bronx, NY USA </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121791997</institution-id><institution-id institution-id-type="GRID">grid.251993.5</institution-id><institution>Department of Psychiatry and Behavioral Sciences, </institution><institution>Albert Einstein College of Medicine, </institution></institution-wrap>1300 Morris Park Ave., Bronx, NY USA </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121791997</institution-id><institution-id institution-id-type="GRID">grid.251993.5</institution-id><institution>Department of Neuroscience, </institution><institution>Albert Einstein College of Medicine, </institution></institution-wrap>1300 Morris Park Ave., Bronx, NY USA </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121791997</institution-id><institution-id institution-id-type="GRID">grid.251993.5</institution-id><institution>Department of Medicine, </institution><institution>Albert Einstein College of Medicine, </institution></institution-wrap>1300 Morris Park Ave., Bronx, NY USA </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121791997</institution-id><institution-id institution-id-type="GRID">grid.251993.5</institution-id><institution>Department of Neurology, </institution><institution>Albert Einstein College of Medicine, </institution></institution-wrap>1300 Morris Park Ave., Bronx, NY USA </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>10</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>10</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>8</volume>
<elocation-id>13</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>5</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>13</day>
<month>8</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>9</day>
<month>10</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2017</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Autism spectrum disorder (ASD) is highly heritable but genetically heterogeneous. The affected neural circuits and cell types remain unclear and may vary at different developmental stages. By analyzing multiple sets of human single cell transcriptome profiles, we found that ASD candidates showed relatively enriched gene expression in neurons, especially in inhibitory neurons. ASD candidates were also more likely to be the hubs of the co-expression gene module that is highly expressed in inhibitory neurons, a feature not detected for excitatory neurons. In addition, we found that upregulated genes in multiple ASD cortex samples were enriched with genes highly expressed in inhibitory neurons, suggesting a potential increase of inhibitory neurons and an imbalance in the ratio between excitatory and inhibitory neurons in ASD brains. Furthermore, the downstream targets of several ASD candidates, such as <italic>CHD8</italic>, <italic>EHMT1</italic> and <italic>SATB2</italic>, also displayed enriched expression in inhibitory neurons. Taken together, our analyses of single cell transcriptomic data suggest that inhibitory neurons may be a major neuron subtype affected by the disruption of ASD gene networks, providing single cell functional evidence to support the excitatory/inhibitory (E/I) imbalance hypothesis.</p>
</abstract>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>Introduction</title>
<p id="Par2">Autism spectrum disorder (ASD) is a class of neurodevelopmental disorders characterized by persistent deficits in social communication/interaction and restricted, repetitive patterns of behaviors, interests or activities (DSM-5)<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Recent epidemiology studies have reported that 1 in 68 children is diagnosed with ASD, with a 3 to 4-fold increased risk for boys<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR3">3</xref></sup>. Family and twin studies have found that ASD is highly heritable<sup><xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR5">5</xref></sup>, but the genetic risk factors for ASD are highly heterogeneous and up to one thousand genes are estimated to be involved, with no single gene accounting for &gt;1–2% of the cases<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. These ASD candidate genes converge on several molecular and cellular pathways, such as synaptic function, Wnt-signal and chromatin remodeling<sup><xref ref-type="bibr" rid="CR7">7</xref>–<xref ref-type="bibr" rid="CR12">12</xref></sup>, indicating that ASD pathogenesis is a complicated multidimensional process modulated by genetic factors that play key roles in response to intrinsic developmental signaling and environmental perturbations.</p>
<p id="Par3">At the cellular level, a human brain can be divided into distinct functional regions that are composed of diverse but densely connected cell types. It has been reported that ASD risk genes form co-expression networks that are expressed at relatively higher levels in specific embryonic prefrontal cortex regions and layers<sup><xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR14">14</xref></sup>, and ASD mutations could potentially affect certain brain areas and cell types more strongly than others<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>. For example, Xu et al. previously developed a method (“cell type-specific expression analysis”) to analyze microarray gene expression data from mouse and human brains, including cell type data from translating ribosome affinity purification (TRAP) technology, and found that multiple cell types could be implicated in ASD<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>, e.g., astrocytes, glia and cortical interneurons. Subsequently, Zhang et al., also using TRAP data from mouse lines, observed that an expression signature shared by ASD risk genes is a strong and positive association with specific neurons in different brain regions, including cortical neurons<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>.</p>
<p id="Par4">A limitation of these previous studies is related to the concern that the resolution of cell types may not be sufficient, in addition to other limitations specifically related to the microarray platform. This can be addressed by single cell RNA-seq (scRNA-seq) analysis that measures gene expression profiles for hundreds to thousands of cells in a tissue sample simultaneously, which can resolve cell types and reveal expression heterogeneity<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. With a mouse scRNA-seq dataset<sup><xref ref-type="bibr" rid="CR19">19</xref></sup> and a novel computational method, Skene et al. suggested that genetic susceptibility of ASD primarily affected interneurons and pyramidal neurons<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. The method is called “expression weighted cell-type enrichment” (EWCE), which evaluates statistically whether a set of genes shows higher expression in a particular cell type than what is expected by chance<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. Skene et al recently also reported that pyramidal cells, medium spiny neurons and certain interneurons could be more important for schizophrenia than other brain cell types<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>.</p>
<p id="Par5">While the above studies have suggested that ASD risk genes can have cell type specific functions and expression patterns, and some brain cell types may be more prone to the effects of ASD-associated mutations, no similar studies have been performed using human cell type-specific functional genomic data, especially scRNA-seq data. This is important because it has been shown that many gene expression modules are human specific, several of which are correlated with brain disorders, such as Alzheimer’s disease<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>, despite the extensive global network similarity of the human and mouse brain transcriptomes. Our previous study of the transcriptional regulatory network modulated by a neural master regulator, REST/NRSF, also found that ASD genes are enriched among human specific REST targets<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. Moreover, the human brain is much more complex than the mouse brain, especially in some regions, such as the frontal and temporal lobes, which have undergone enormous changes during primate evolution<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. More importantly, no systematic studies related to ASD have been carried out in which excitatory and inhibitory neuronal transcriptomes have been compared, despite the long-standing E/I imbalance hypothesis, which has been proposed as a model to explain some ASD-related behaviors<sup><xref ref-type="bibr" rid="CR25">25</xref>–<xref ref-type="bibr" rid="CR28">28</xref></sup>. Therefore, to address if some cell types are more prone to genetic network disruptions potentially occurring in the brains of individuals with ASD, we have collected multiple human neural or brain expression datasets, most of which were derived from advanced scRNA-seq analysis, and evaluated if genes implicated in ASD show different expression profiles across human neural cell types. The gene sets in our study include a) ASD candidate genes, b) differentially expressed genes between ASD individuals and controls, and c) downstream targets of several ASD candidates. We found that these genes consistently show significantly enriched expression in human neurons, particularly inhibitory neuron, suggesting that inhibitory neuron is the major cell type affected in ASD. This finding is consistent with the hypothesis that a disruption of the balance between inhibitory and excitatory signaling could be an important underlying mechanism of ASD pathogenesis.</p>
</sec>
<sec id="Sec2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="Sec3">
<title>Human single cell RNA-seq data</title>
<p id="Par6">Four sets of human scRNA-seq data were analyzed. For the fetal brain and cerebral organoid datasets<sup><xref ref-type="bibr" rid="CR29">29</xref></sup> and the adult brain dataset<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>, raw scRNA-seq reads were aligned to the human reference genome (GRCh37/hg19) using STAR (ver. 2.0.13)<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>. Duplicate reads were removed using Samtools (ver. 0.1.19)<sup><xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR33">33</xref></sup>. Gene length and uniquely mapped reads for each gene were calculated using featureCounts in subread package (ver. 1.4.6)<sup><xref ref-type="bibr" rid="CR34">34</xref></sup> with gene models from Ensembl release 74. Fragments per kilobase of transcript per million mapped reads (FPKM) values were calculated using R (<ext-link ext-link-type="uri" xlink:href="https://www.r-project.org/">https://www.r-project.org/</ext-link>) according to its definition. For the neuron subtype dataset for excitatory and inhibitory neurons, transcripts per kilobase million (TPMs) were obtained from the original paper<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>. In all four cases, we used the authors’ original classification of cell types.</p>
</sec>
<sec id="Sec4">
<title>Lists of genes associated with ASD, schizophrenia and other brain disorders</title>
<p id="Par7">ASD candidate genes were downloaded from the SFARI database (<ext-link ext-link-type="uri" xlink:href="https://gene.sfari.org/autdb/GS_Home.do">https://gene.sfari.org/autdb/GS_Home.do</ext-link>; genes scored as high confidence, to minimal evidence and syndromic) and the AutismKB (core dataset)<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. The two schizophrenia gene lists were from the SZgene database<sup><xref ref-type="bibr" rid="CR37">37</xref></sup> and a recent GWAS report<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. Bipolar disorder associated genes were from the BDgene database<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. Other gene lists associated with brain diseases were described in our previous publication<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. Genes encoding excitatory and inhibitory postsynaptic density (PSD) proteins were from a previous study by Uezu et al.<sup><xref ref-type="bibr" rid="CR40">40</xref></sup> The genes associated with human height were from a previous GWAS<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. Gene lists were provided in Table <xref ref-type="media" rid="MOESM5">S1</xref>.</p>
</sec>
<sec id="Sec5">
<title>Differentially expressed genes between ASD and controls</title>
<p id="Par8">Gene expression in postmortem cortices (“Cortex1”)<sup><xref ref-type="bibr" rid="CR42">42</xref></sup> was used to detect differentially expressed genes by GEO2R (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/geo2r/">https://www.ncbi.nlm.nih.gov/geo/geo2r/</ext-link>), which is defined here as FDR &lt; 0.05 and fold change &gt; 1.3—the same criteria as used in the original paper. Differentially expressed genes in blood<sup><xref ref-type="bibr" rid="CR43">43</xref></sup> were also detected by GEO2R and defined as <italic>p</italic> &lt; 0.05. Gene lists from other brain-related samples, including postmortem cortices (“Cortex2”<sup><xref ref-type="bibr" rid="CR44">44</xref></sup> and “Cortex3”<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>), induced pluripotent stem cell (iPSC)-derived cerebral organoids (“Organoid”)<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>, neural progenitor cells (NPC)<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>, and neurons (“Neuron1”<sup><xref ref-type="bibr" rid="CR47">47</xref></sup> and “Neuron2”<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>), were obtained from the original papers and provided in Table <xref ref-type="media" rid="MOESM5">S1</xref>.</p>
</sec>
<sec id="Sec6">
<title>Downstream genes of ASD candidates</title>
<p id="Par9">CHD8-regulated genes in NPCs, neurons<sup><xref ref-type="bibr" rid="CR49">49</xref></sup> and cerebral organoids<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>, CYFIP1-regulated genes<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>, TCF4 and EHMT1-regulated genes<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>, MBD5 and SATB2-regulated genes<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>, NRXN1-regulated genes<sup><xref ref-type="bibr" rid="CR54">54</xref></sup> and ZNF804A-regulated genes<sup><xref ref-type="bibr" rid="CR55">55</xref></sup> were from studies where the expression of a known ASD candidate was reduced by knockout or knockdown. Gene lists were obtained from the original papers and provided in Table <xref ref-type="media" rid="MOESM5">S1</xref>.</p>
</sec>
<sec id="Sec7">
<title>EWCE analysis for determining enriched expression</title>
<p id="Par10">For each cell type, mean of log2(FPKM or TPM) across all samples were calculated and imported into the EWCE (v1.3.0)<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> to determine enriched expression. To determine specifically which genes contributed to the statistical significance of enriched expression, we used the “generate.bootstrap.plots” function in EWCE with 10,000 permutations to generate “mean bootstrap expression” (see Fig. <xref ref-type="fig" rid="Fig2">2</xref> in the EWCE paper<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> for details). We further defined genes whose relative expression was &gt;1.2-fold greater than the mean bootstrap expression as “enriched genes”. The resultant lists of enriched genes were analyzed for enriched gene ontology (FDR &lt; 0.05) using the software goseq<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>, in which the corresponding full gene list was used as background.</p>
</sec>
<sec id="Sec8">
<title>Weighted gene co-expression network analysis (WGCNA)</title>
<p id="Par11">Signed co-expression networks were built using the WGCNA package<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>. The power of 18 was chosen, and blockwiseModules function was performed to build networks. Logistic regression was used to find modules expressed higher in excitatory or inhibitory neurons using eigengenes. P values were corrected by multiple testing to generate FDR. ToppGene<sup><xref ref-type="bibr" rid="CR58">58</xref></sup> was used to find Gene Ontology categories enriched in modules.</p>
</sec>
<sec id="Sec9">
<title>Code availability</title>
<p id="Par12">The primary software EWCE (v1.3.0)<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> was downloaded from <ext-link ext-link-type="uri" xlink:href="https://www.bioconductor.org/packages/release/bioc/html/EWCE.html">https://www.bioconductor.org/packages/release/bioc/html/EWCE.html</ext-link>. Additional codes for data processing are available from the authors upon request. An early version of this manuscript<sup><xref ref-type="bibr" rid="CR59">59</xref></sup> was submitted to bioRxiv before publication.</p>
</sec>
</sec>
<sec id="Sec10" sec-type="results">
<title>Results</title>
<sec id="Sec11">
<title>ASD candidate genes show enriched expression in neurons, especially inhibitory neurons</title>
<p id="Par13">It has generally been supposed that functional disruptions of a gene more likely affect the cells or tissues where the gene is highly expressed. Such a principle has often been used to support the discovery of risk genes from genetic studies in schizophrenia and ASD<sup><xref ref-type="bibr" rid="CR38">38</xref>,<xref ref-type="bibr" rid="CR60">60</xref></sup>. Accordingly, we have used the EWCE method to test what brain cell types are more likely to be affected by genes implicated in ASD, using transcriptomic data containing cell type identifies. Throughout this paper, the term “enrichment expression” or “enriched expression” in a particular cell type refers to a set of genes that have a higher level of expression within this cell type than expected by chance, as described in the EWCE method<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. The method also accounts for a gene’s overall expression across all cell types in a comparison, as the enrichment is actually computed based on relative expression values. We started with scRNA-seq expression data from six cell types from adult human brains (21–63 years old; a total of 285 cells), including neurons, microglia, and astrocytes (Fig. <xref ref-type="fig" rid="Fig1">1a</xref>)<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. First, as a negative control, we found that genes associated with human height<sup><xref ref-type="bibr" rid="CR41">41</xref></sup> showed no enrichment of expression in any of the six cell types in test (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). Conversely, as a positive control, genes encoding PSD proteins showed significant enrichment in neuron expression (Fig. <xref ref-type="fig" rid="Fig1">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Cell type enrichment analysis of genes associated with ASD or other brain disorders across multiple single cell transcriptome datasets. <bold>a</bold> Adult brains, <bold>b</bold> Fetal brains, <bold>c</bold> Cerebral organoids, and <bold>d</bold> Neuron subtypes. The color in each panel represents fold enrichment, calculated as the expression of the target gene lists divided by the mean expression of the randomly selected genes in bootstrap sampling by EWCE. The number in individual boxes represents significant adjusted p value (FDR &lt; 0.05). <italic>ePSD</italic> excitatory postsynaptic density, <italic>iPSD</italic> inhibitory postsynaptic density, <italic>OPC</italic> oligodendrocyte precursor cell, <italic>AP</italic> apical progenitor, <italic>BP</italic> basal progenitor, <italic>N</italic> neuron, <italic>NPC</italic> neural progenitor cells, <italic>Ex</italic> excitatory neuron, <italic>In</italic> inhibitory neuron. The same annotations are used for the colors and numbers of the boxes in Figs <xref ref-type="fig" rid="Fig3">3</xref> and <xref ref-type="fig" rid="Fig4">4</xref> below</p></caption><graphic id="d29e698" xlink:href="41398_2017_58_Fig1_HTML"></graphic></fig>
</p>
<p id="Par14">Our analysis of the ASD candidates, obtained from either the SFARI (<ext-link ext-link-type="uri" xlink:href="https://gene.sfari.org/autdb/GS_Home.do">https://gene.sfari.org/autdb/GS_Home.do</ext-link>) or the AutismKB<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>, demonstrated that their expression was significantly enriched in human adult neurons and oligodendrocyte precursor cells but not astrocytes and microglia (Fig. <xref ref-type="fig" rid="Fig1">1a</xref>). Note that the significance of enrichment was a result of many but not few genes (Fig. <xref ref-type="media" rid="MOESM1">S1</xref>), an observation applicable to results described below too (Table <xref ref-type="media" rid="MOESM6">S2</xref>). As ASD is an early developmental disorder, we repeated the same analysis using a single cell transcriptome dataset from human fetal brains, including 226 single-cell transcriptomes from 12 and 13-wk post-conception neocortex specimens<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. The cell types in the fetal brain were classified differently from those in adult brains. We found that in comparison to apical and basal progenitors, ASD candidates were significantly enriched in neurons, especially mature neurons (“N2” and “N3”) in fetal brains (Fig. <xref ref-type="fig" rid="Fig1">1b</xref>). We also found schizophrenia and bipolar disorder associated genes were similarly enriched in mature neurons (Fig. <xref ref-type="fig" rid="Fig1">1b</xref>), consistent with the known overlap of genetic risk factors among these disorders<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>. Meanwhile, genes associated with several other brain diseases, such as Alzheimer and Huntington, showed no significantly enriched expression in any of these cell types (Fig. <xref ref-type="fig" rid="Fig1">1b</xref>). Next, to study whether ASD candidates are enriched in neurons in specific brain regions, we analyzed single cell transcriptome data of cerebral organoids, including 495 single-cell transcriptomes<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. Again, compared with NPCs, ASD candidates displayed significantly enriched expression in neurons - both dorsal and ventral forebrain neurons, as were schizophrenia and bipolar disorder associated genes (Fig. <xref ref-type="fig" rid="Fig1">1c</xref>). While not quite surprising, our analysis of these three cell type transcriptomic datasets showed that neurons, both early fetal neurons and adult neurons, are a major cell type potentially affected by ASD mutations, probably more so than neural progenitors. Finally, neurons could be largely classified into two major subtypes: excitatory and inhibitory neurons. Using scRNA-seq data of neuronal subtypes, whose classification was supported by known marker genes and including 3083 single-cell transcriptomes from six cortical regions of a control normal 51-year-old female postmortem brain<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>, we found that the expression of ASD candidates was significantly enriched in inhibitory neurons, especially among the subtypes “In1” and “In3” (Fig. <xref ref-type="fig" rid="Fig1">1d</xref>), which are superficial layer inhibitory neurons that originate from lateral ganglionic eminences<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>. These results suggest that functional disruptions of ASD genes as a group can affect inhibitory neurons more than excitatory neurons. Again, the significant enrichments were results from many genes (Fig. <xref ref-type="media" rid="MOESM2">S2</xref>). For ASD genes, the expression “enriched genes” (see Methods) include neuronal markers, such as <italic>GAD1</italic>, <italic>RELN</italic>, <italic>VIP</italic>, as expected, and transcription regulators, such as <italic>CHD7</italic>, <italic>PAX6</italic> and <italic>TBX1</italic> (Table <xref ref-type="media" rid="MOESM6">S2</xref>). Although it remains to be established with functional assays, this finding indicates that inhibitory neuron transcriptome dysregulation can occur in ASD brains, which is consistent with the E/I imbalance hypothesis in ASD<sup><xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR62">62</xref>–<xref ref-type="bibr" rid="CR65">65</xref></sup>. GABAergic neurotransmission appears to play a role in both schizophrenia and bipolar disorder as well<sup><xref ref-type="bibr" rid="CR66">66</xref>,<xref ref-type="bibr" rid="CR67">67</xref></sup>. However, our results suggest that bipolar disorder but not schizophrenia-associated genes were significantly enriched among highly expressing genes in inhibitory neurons.</p>
</sec>
<sec id="Sec12">
<title>ASD candidate genes are more likely to be hubs of co-expression modules in inhibitory neurons</title>
<p id="Par15">To further study the roles of ASD candidate genes in inhibitory neurons, we performed WGCNA to build a co-expression network from the neural subtype transcriptome data<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>, resulting in 73 modules (Figure <xref ref-type="media" rid="MOESM3">S3A and B</xref>). One of them showed high expression in excitatory neurons and contained 1936 genes, which were enriched for functions related to synaptic signaling, neuron projection and morphogenesis, as well as genes expressed in excitatory synapses (Figure <xref ref-type="media" rid="MOESM3">S3</xref>,<xref ref-type="media" rid="MOESM1">C</xref>). Another module contained 951 genes that were highly expressed in inhibitory neurons. They were enriched with genes involved in neurogenesis, positive regulation of synaptic transmission, and the GABA shunt (Figure <xref ref-type="media" rid="MOESM3">S3</xref>,<xref ref-type="media" rid="MOESM1">D</xref>). Consistent with the EWCE result, ASD candidates, from both the SFARI and AutismKB, were more significantly enriched in the module highly expressed in inhibitory neurons (odds ratio (OR) = 2.38, <italic>p</italic> = 5.94e-07, Fisher’s exact test, one-tailed) than the module highly expressed in excitatory neurons (OR = 1.42, <italic>p</italic> = 0.018, Fisher’s exact test, one-tailed). Among the hub genes in the inhibitory module, nine were ASD candidates (Fig. <xref ref-type="fig" rid="Fig2">2a</xref>), including three genes encoding transcription factors (<italic>ARX</italic>, <italic>DLX2,</italic> and <italic>DLX6</italic>) that are important for appropriate migration of inhibitory neurons to the cortex<sup><xref ref-type="bibr" rid="CR68">68</xref></sup>, and three genes (<italic>SLC6A1</italic>, <italic>GAD1</italic>, <italic>ALDH5A1</italic>) that participate in GABA synthesis, release, reuptake and degradation, as described in the Reactome pathway<sup><xref ref-type="bibr" rid="CR69">69</xref></sup>. Notably, those ASD candidate genes had more connections in the inhibitory module than non-ASD candidates (<italic>p</italic> = 0.0057, Wilcoxon test; Fig. <xref ref-type="fig" rid="Fig2">2b</xref>), suggesting that ASD candidates tend to be the hubs in inhibitory module, and consequently, disease-associated mutations would likely lead to a disruption of the co-expression network. By comparison, in the excitatory module, ASD and non-ASD candidate genes had similar connections (<italic>p</italic> = 0.72, Wilcoxon test; Fig. <xref ref-type="fig" rid="Fig2">2c, d</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><p>Visualization of gene co-expression module associated with excitatory and inhibitory neurons. Genes with co-expression coefficient &gt; 0.2 from the WGCNA are shown as a network for <bold>a</bold> inhibitory and <bold>c</bold> excitatory modules. Node size represents the number of connected genes. Darker nodes are ASD candidate genes. Boxplots show the number of connections for ASD and non-ASD genes in inhibitory <bold>b</bold> and excitatory <bold>d</bold> modules. * p&lt;0.05 Wilcoxon test</p></caption><graphic id="d29e894" xlink:href="41398_2017_58_Fig2_HTML"></graphic></fig>
</p>
</sec>
<sec id="Sec13">
<title>Genes up-regulated in ASD-derived neuronal samples show enrichment in inhibitory neurons</title>
<p id="Par16">Because of the extensive genetic heterogeneity in ASD, investigators have carried out transcriptomic studies in postmortem samples or ASD patient-derived neural samples with the goals of finding common pathways and cellular processes dysregulated in ASD brains or neural samples<sup><xref ref-type="bibr" rid="CR42">42</xref>–<xref ref-type="bibr" rid="CR48">48</xref></sup>. We thus decided to study whether differentially expressed genes (DEGs) in molecular studies carried out between ASD and control subjects exhibited similar cell type-biased expression patterns as ASD candidate genes identified from genetic studies. We obtained DEGs in ASD brain or blood samples and analyzed their expression across brain cell types. Since, as shown above, we had uncovered the biased expression pattern of ASD candidate genes (from SFARI or AutismKB), we excluded them from the DEGs during EWCE analysis, in order to focus on downstream effects. In ASD cortex samples, up-regulated genes were enriched with genes highly expressed in adult astrocytes and microglia (Fig. <xref ref-type="media" rid="MOESM4">S4A</xref>), whereas down-regulated genes were enriched with genes highly expressed in neurons (Fig. <xref ref-type="media" rid="MOESM4">S4B</xref>). This is consistent with previous reports<sup><xref ref-type="bibr" rid="CR42">42</xref>,<xref ref-type="bibr" rid="CR44">44</xref>,<xref ref-type="bibr" rid="CR45">45</xref></sup>, but extends the finding to relatively mature neurons and both dorsal and ventral forebrain neurons (Fig. <xref ref-type="media" rid="MOESM4">S4</xref>,<xref ref-type="media" rid="MOESM1">B</xref>). We also found up-regulated genes in ASD cortex samples were enriched for highly expressed genes in NPCs (Fig. <xref ref-type="media" rid="MOESM4">S4</xref>,<xref ref-type="media" rid="MOESM1">A</xref>), a pattern not detected when ASD candidates were analyzed (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). However, genes up-regulated in NPCs, neurons and cerebral organoids derived from ASD iPSC-lines showed enriched expression in neurons (Fig. <xref ref-type="media" rid="MOESM4">S4</xref>,<xref ref-type="media" rid="MOESM1">A</xref>), while down-regulated genes in the patient-derived samples were enriched with genes expressed highly in astrocytes, microglia and NPCs (Fig. <xref ref-type="media" rid="MOESM4">S4</xref>,<xref ref-type="media" rid="MOESM1">B</xref>). These results suggest that cell types can be affected differently in early and late developing ASD brains. The difference may also reflect primary vs secondary effects. However, in our comparison of excitatory vs inhibitory neurons, we found that up-regulated genes in both postmortem cortices and cerebral organoids were similarly enriched with genes highly expressed in inhibitory neurons (Fig. <xref ref-type="fig" rid="Fig3">3a</xref>). In a group of upregulated genes in ASD cortices (Cortex3_C1), enriched genes for In4 were enriched with regulation of cell motility; in upregulated genes in ASD-derived organoids (Organoid_TD11), enriched genes for In1 and In4 were enriched with DNA binding (Table <xref ref-type="media" rid="MOESM7">S3</xref>). The down-regulated genes from cortices and iPSC-derived neurons or cerebral organoids exhibited opposite enrichments, with the former enriched for high expression in excitatory and the latter in inhibitory neurons (Fig. <xref ref-type="fig" rid="Fig3">3b</xref>). Importantly, dysregulated genes in ASD blood samples<sup><xref ref-type="bibr" rid="CR43">43</xref></sup> did not exhibit any significant pattern of expression enrichment.<fig id="Fig3"><label>Fig. 3</label><caption><p>Cell type enrichment analysis of upregulated <bold>a</bold> and downregulated <bold>b</bold> genes in ASD samples. Note that ASD candidates from SFARI or AutismKB have been excluded from DEGs</p></caption><graphic id="d29e981" xlink:href="41398_2017_58_Fig3_HTML"></graphic></fig>
</p>
</sec>
<sec id="Sec14">
<title>Downstream transcriptional targets of key ASD candidates are enriched among genes expressed highly in inhibitory neurons</title>
<p id="Par17">Finally, we studied whether the downstream targets of ASD candidates genes show different expression enrichment patterns between inhibitory and excitatory neurons by analyzing the DEGs in human neural samples in which the expression of several top ASD (or schizophrenia) candidate genes have been reduced by either knockout or knockdown. We found that CHD8, EHMT1 and SATB2 regulated genes were exclusively enriched in inhibitory neurons (Fig. <xref ref-type="fig" rid="Fig4">4</xref>). For CHD8 regulated genes in iPSC derived neurons, expressionally enriched genes for In1/2/3/8 were functionally enriched for single-multicellular organism process; for SATB2 regulated genes, enriched genes were enriched with embryonic organ development; for CYFIP1 regulated genes, enriched genes for In2 and In4 are enriched with cell differentiation and locomotion, respectively (Table <xref ref-type="media" rid="MOESM7">S3</xref>). Moreover, a general enrichment in inhibitory neuronal genes, especially those in “In1/2/3” classes, was found among the targets of ASD candidates (Fig. <xref ref-type="fig" rid="Fig4">4</xref>). Among the downstream targets, <italic>DLX1</italic>, a transcription factor critical for inhibitory neuron function is markedly upregulated in ASD patient-derived telencephalic organoids<sup><xref ref-type="bibr" rid="CR46">46</xref></sup> and <italic>CHD8</italic> knockout cerebral organoids<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>, but <italic>GAD1</italic>, an inhibitory neuron marker, was downregulated in <italic>SATB2</italic> knockdown samples<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>. We analyzed DEGs from <italic>CYFIP1</italic> knockdown in NPCs derived from three independent iPSC-lines and found both common and distinct enriched expression patterns. DEGs from two lines (C2 and C5) were enriched in inhibitory neurons, but C4 DEGs showed enriched expression in excitatory neurons (Fig. <xref ref-type="fig" rid="Fig4">4</xref>). This difference could reflect the limited overlap of the DEGs<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>, but also suggests an intriguing possibility that E/I imbalances could be affected by inter-individual differences in genetic background. We should point out that <italic>CHD8</italic> and <italic>EHMT1</italic> are expressed at a similar level in excitatory and inhibitory neurons, but <italic>SATB2</italic> is expressed at a higher level in excitatory neurons. These findings further suggest that some ASD genes can affect the expression of key genes important for inhibitory and excitatory neurons and their targets may be involved in the interaction or signaling balance between the two types of neurons.<fig id="Fig4"><label>Fig. 4</label><caption><p>Cell type enrichment analysis of downstream targets of ASD candidates</p></caption><graphic id="d29e1050" xlink:href="41398_2017_58_Fig4_HTML"></graphic></fig>
</p>
</sec>
</sec>
<sec id="Sec15" sec-type="discussion">
<title>Discussion</title>
<p id="Par18">By integrating ASD candidates, dysregulated genes in ASD samples and downstream targets of ASD candidates with recently published human scRNA-seq datasets, we found that ASD-associated genes exhibited enriched expression in neurons, especially inhibitory neurons, with some developmental stage differences. The enrichment of inhibitory neuronal expression among ASD candidate genes provides molecular support for the finding that deficits in inhibitory neuronal function occurs in some syndromes with autism-associated behaviors, such as individuals with <italic>ARX</italic> mutations<sup><xref ref-type="bibr" rid="CR70">70</xref>,<xref ref-type="bibr" rid="CR71">71</xref></sup>, Dravet syndrome caused by loss-of-function mutations in <italic>SCN1A</italic>
<sup><xref ref-type="bibr" rid="CR72">72</xref></sup>, and Tuberous Sclerosis caused by mutations in <italic>TSC1/2</italic>
<sup><xref ref-type="bibr" rid="CR73">73</xref>,<xref ref-type="bibr" rid="CR74">74</xref></sup> (for review, see ref. <sup><xref ref-type="bibr" rid="CR75">75</xref></sup>). Our current findings are in line with the long-standing hypothesis that E/I signaling imbalance contributes to ASD. The attractive theory of an increase in the ratio between excitatory and inhibitory signaling provides a plausible explanation for the relative reduction in GABAergic signaling found in patients with ASD and their propensity to develop epilepsy<sup><xref ref-type="bibr" rid="CR75">75</xref></sup>. However, a relative excess of inhibitory neuronal activity has been observed in mouse models of Rett Syndrome<sup><xref ref-type="bibr" rid="CR76">76</xref></sup>, and mice with a targeted <italic>Mecp2</italic> deletion restricted to GABAergic inhibitory neurons recapitulates most of the ASD-like features observed in animal models<sup><xref ref-type="bibr" rid="CR77">77</xref></sup>, while restoring <italic>Mecp2</italic> expression reverses some of the phenotypical defects<sup><xref ref-type="bibr" rid="CR78">78</xref>,<xref ref-type="bibr" rid="CR79">79</xref></sup>.</p>
<p id="Par19">Our analysis showed enriched expression in inhibitory neurons for upregulated but not down-regulated genes in ASD samples. This seems inconsistent with the enriched expression of ASD candidates in inhibitory neurons, assuming their mutations lead to reduced expression and functional loss. One possibility is that some ASD candidates may function as transcriptional inhibitors or the abnormal expression of some ASD candidates could lead to an increase in the number of inhibitory neurons, in a subset of ASD subjects or in certain brain regions, perhaps as a compensation mechanism for a reduction of GABA receptors (or GABAergic function) in individual inhibitory neurons<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>. However, previous studies have reported an overproduction of GABAergic inhibitory neurons in ASD iPSC-derived organoids<sup><xref ref-type="bibr" rid="CR46">46</xref></sup> and neural cells<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>, with the former likely resulting from increased <italic>FOXG1</italic> expression<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>, suggesting that an increase in inhibitory interneuron function could be due to a direct effect of some candidate genes. Another key transcription factor in GABAergic interneuron differentiation, <italic>DLX1</italic>, was also upregulated in <italic>CHD8</italic> knockout NPCs, neurons<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>, and cerebral organoids<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. Furthermore, our study indicates that both primary and secondary ASD-affected genes may play roles in inhibitory neurogenesis and function, contributing to ASD pathogenesis. We should note that when, where and how an E/I imbalance contributes to ASD is unclear and certainly beyond the scope of the current study. Nevertheless, it is conceivable that E/I imbalance may tilt to one direction in a subset of ASD but to the other in a different subset.</p>
<p id="Par20">Since neuronal subtype transcriptomes used in the current study were from an adult female brain<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>, and there are significant transcriptional (and structural) differences in the brain between the pre- to post-natal period, and from the teenage to adult stage<sup><xref ref-type="bibr" rid="CR80">80</xref></sup>, it would be interesting to perform a similar EWCE study using scRNA-seq data from prenatal or fetal neurons in multiple brain regions from both sexes. Considering our findings, it is interesting to note that drugs targeting inhibitory neuron function are being developed to treat ASD<sup><xref ref-type="bibr" rid="CR81">81</xref></sup>. Consequently, it would be valuable to study their effects in early and late developing brains, animal models, iPSC models, and in ASD subjects using brain imaging and electrophysiology to fully explore the therapeutic potential of such drugs.</p>
<p id="Par21">Finally, we found that upregulated genes in postmortem ASD brains were enriched in microglia and astrocytes, which is consistent with original reports based on the mouse transcriptome<sup><xref ref-type="bibr" rid="CR42">42</xref>,<xref ref-type="bibr" rid="CR44">44</xref></sup>. This is consistent with the findings that activated microglia and astrocytosis occur in multiple brain regions of ASD patients<sup><xref ref-type="bibr" rid="CR82">82</xref>,<xref ref-type="bibr" rid="CR83">83</xref></sup>. However, ASD candidate themselves did not show such an enrichment in our analysis. Thus, dysregulation of neuron-glia signaling might be a secondary process in response to the initial insults elicited by the primary casual genetic variants, a testable hypothesis.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Electronic supplementary material</title>
<sec id="Sec16">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41398_2017_58_MOESM1_ESM.pdf"><caption><p>Figure S1</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41398_2017_58_MOESM2_ESM.pdf"><caption><p>Figure S2</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="41398_2017_58_MOESM3_ESM.pdf"><caption><p>Figure S3</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="41398_2017_58_MOESM4_ESM.pdf"><caption><p>Figure S4</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM5"><media xlink:href="41398_2017_58_MOESM5_ESM.xlsx"><caption><p>Table S1</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM6"><media xlink:href="41398_2017_58_MOESM6_ESM.xlsx"><caption><p>Table S2</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM7"><media xlink:href="41398_2017_58_MOESM7_ESM.xlsx"><caption><p>Table S3</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM8"><media xlink:href="41398_2017_58_MOESM8_ESM.docx"><caption><p>file with changes highlighted</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn>
<p>
<bold>Publisher's note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
<fn>
<p>
<bold>Supplementary information</bold>
</p>
<p>The online version of this article (doi:10.1038/s41398-017-0058-6) contains supplementary material.</p>
</fn>
</fn-group>
<ack>
<title>Acknowledgements</title>
<p>This study is supported by NIH grants (MH099427 to HL and HL133120 to DZ). We thank the High Performance Computing division at the Albert Einstein College of Medicine for computing support. We also acknowledge supports by the Albert Einstein College of Medicine’s Rose F. Kennedy Intellectual and Developmental Disabilities Research Center and by the National Institutes of Health’s National Institute of Child Health and Human Development (NIH/NICHD) grant P30 HD071593.</p>
</ack>
<notes notes-type="COI-statement">
<sec id="FPar1">
<title>Competing interests</title>
<p id="Par38">The authors declare that they have no competing financial interest.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<mixed-citation publication-type="other">Wingate M. <italic>et al</italic>. Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2010. <italic>Mmwr Surveill Summ</italic><bold>63</bold>, (2014).</mixed-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Developmental Disabilities Monitoring Network Surveillance Year Principal I, Centers for Disease C, Prevention.</collab>
</person-group>
<article-title>Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010</article-title>
<source/>MMWR. Surveill. Summ.
          <year>2014</year>
<volume>63</volume>
<fpage>1</fpage>
<lpage>21</lpage>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loomes</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hull</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mandy</surname>
<given-names>WPL</given-names>
</name>
</person-group>
<article-title>What Is the Male-to-Female Ratio in Autism Spectrum Disorder? A Systematic Review and Meta-Analysis</article-title>
<source/>J. Am. Acad. Child. Adolesc. Psychiatr.
          <year>2017</year>
<volume>56</volume>
<fpage>466</fpage>
<lpage>474</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaac.2017.03.013</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sandin</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The familial risk of autism</article-title>
<source/>JAMA.
          <year>2014</year>
<volume>311</volume>
<fpage>1770</fpage>
<lpage>1777</lpage>
<pub-id pub-id-type="doi">10.1001/jama.2014.4144</pub-id>
<pub-id pub-id-type="pmid">24794370</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Folstein</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rutter</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Genetic influences and infantile autism</article-title>
<source/>Nature.
          <year>1977</year>
<volume>265</volume>
<fpage>726</fpage>
<lpage>728</lpage>
<pub-id pub-id-type="doi">10.1038/265726a0</pub-id>
<pub-id pub-id-type="pmid">558516</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Rubeis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Buxbaum</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>Genetics and genomics of autism spectrum disorder: embracing complexity</article-title>
<source/>Hum. Mol. Genet.
          <year>2015</year>
<volume>24</volume>
<fpage>R24</fpage>
<lpage>R31</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddv273</pub-id>
<pub-id pub-id-type="pmid">26188008</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krumm</surname>
<given-names>N</given-names>
</name>
<name>
<surname>O’Roak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Shendure</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Eichler</surname>
<given-names>EE</given-names>
</name>
</person-group>
<article-title>A de novo convergence of autism genetics and molecular neuroscience</article-title>
<source/>Trends. Neurosci.
          <year>2014</year>
<volume>37</volume>
<fpage>95</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2013.11.005</pub-id>
<pub-id pub-id-type="pmid">24387789</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de la Torre-Ubieta</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Won</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
</person-group>
<article-title>Advancing the understanding of autism disease mechanisms through genetics</article-title>
<source/>Nat. Med.
          <year>2016</year>
<volume>22</volume>
<fpage>345</fpage>
<lpage>361</lpage>
<pub-id pub-id-type="doi">10.1038/nm.4071</pub-id>
<pub-id pub-id-type="pmid">27050589</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Penagarikano</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Belgard</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Swarup</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
</person-group>
<article-title>The emerging picture of autism spectrum disorder: genetics and pathology</article-title>
<source/>Annu. Rev. Pathol.
          <year>2015</year>
<volume>10</volume>
<fpage>111</fpage>
<lpage>144</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-pathol-012414-040405</pub-id>
<pub-id pub-id-type="pmid">25621659</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Willsey</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>State</surname>
<given-names>MW</given-names>
</name>
</person-group>
<article-title>Autism spectrum disorders: from genes to neurobiology</article-title>
<source/>Curr. Opin. Neurobiol.
          <year>2015</year>
<volume>30</volume>
<fpage>92</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="doi">10.1016/j.conb.2014.10.015</pub-id>
<pub-id pub-id-type="pmid">25464374</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeste</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
</person-group>
<article-title>Disentangling the heterogeneity of autism spectrum disorder through genetic findings</article-title>
<source/>Nat Rev Neurol
          <year>2014</year>
<volume>10</volume>
<fpage>74</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1038/nrneurol.2013.278</pub-id>
<pub-id pub-id-type="pmid">24468882</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huguet</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ey</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bourgeron</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>The genetic landscapes of autism spectrum disorders</article-title>
<source/>Annu. Rev. Genomics. Hum. Genet.
          <year>2013</year>
<volume>14</volume>
<fpage>191</fpage>
<lpage>213</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-genom-091212-153431</pub-id>
<pub-id pub-id-type="pmid">23875794</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Willsey</surname>
<given-names>AJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism</article-title>
<source/>Cell
          <year>2013</year>
<volume>155</volume>
<fpage>997</fpage>
<lpage>1007</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2013.10.020</pub-id>
<pub-id pub-id-type="pmid">24267886</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parikshak</surname>
<given-names>NN</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism</article-title>
<source/>Cell
          <year>2013</year>
<volume>155</volume>
<fpage>1008</fpage>
<lpage>1021</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2013.10.031</pub-id>
<pub-id pub-id-type="pmid">24267887</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gilman</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Vitkup</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Genotype to phenotype relationships in autism spectrum disorders</article-title>
<source/>Nat. Neurosci.
          <year>2015</year>
<volume>18</volume>
<fpage>191</fpage>
<lpage>198</lpage>
<pub-id pub-id-type="doi">10.1038/nn.3907</pub-id>
<pub-id pub-id-type="pmid">25531569</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wells</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>O’Brien</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Nehorai</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dougherty</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>Cell type-specific expression analysis to identify putative cellular mechanisms for neurogenetic disorders</article-title>
<source/>J. Neurosci.
          <year>2014</year>
<volume>34</volume>
<fpage>1420</fpage>
<lpage>1431</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4488-13.2014</pub-id>
<pub-id pub-id-type="pmid">24453331</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>A Cell Type-Specific Expression Signature Predicts Haploinsufficient Autism-Susceptibility Genes</article-title>
<source/>Hum. Mutat.
          <year>2017</year>
<volume>38</volume>
<fpage>204</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="doi">10.1002/humu.23147</pub-id>
<pub-id pub-id-type="pmid">27860035</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stegle</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Teichmann</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Marioni</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>Computational and analytical challenges in single-cell transcriptomics</article-title>
<source/>Nat. Rev. Genet.
          <year>2015</year>
<volume>16</volume>
<fpage>133</fpage>
<lpage>145</lpage>
<pub-id pub-id-type="doi">10.1038/nrg3833</pub-id>
<pub-id pub-id-type="pmid">25628217</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeisel</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Brain structure. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq</article-title>
<source/>Science
          <year>2015</year>
<volume>347</volume>
<fpage>1138</fpage>
<lpage>1142</lpage>
<pub-id pub-id-type="doi">10.1126/science.aaa1934</pub-id>
<pub-id pub-id-type="pmid">25700174</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skene</surname>
<given-names>NG</given-names>
</name>
<name>
<surname>Grant</surname>
<given-names>SG</given-names>
</name>
</person-group>
<article-title>Identification of Vulnerable Cell Types in Major Brain Disorders Using Single Cell Transcriptomes and Expression Weighted Cell Type Enrichment</article-title>
<source/>Front Neurosci
          <year>2016</year>
<volume>10</volume>
<fpage>16</fpage>
<pub-id pub-id-type="doi">10.3389/fnins.2016.00016</pub-id>
<pub-id pub-id-type="pmid">26858593</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<mixed-citation publication-type="other">Skene, N. G. <italic>et al</italic>. Genetic Identification Of Brain Cell Types Underlying Schizophrenia. <italic>bioRxiv</italic> 2017. doi:https://doi.org/10.1101/145466</mixed-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Horvath</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
</person-group>
<article-title>Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2010</year>
<volume>107</volume>
<fpage>12698</fpage>
<lpage>12703</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0914257107</pub-id>
<pub-id pub-id-type="pmid">20616000</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rockowitz</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Significant expansion of the REST/NRSF cistrome in human versus mouse embryonic stem cells: potential implications for neural development</article-title>
<source/>Nucleic. Acids. Res.
          <year>2015</year>
<volume>43</volume>
<fpage>5730</fpage>
<lpage>5743</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkv514</pub-id>
<pub-id pub-id-type="pmid">25990720</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Rakic</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Cortical evolution: judge the brain by its cover</article-title>
<source/>Neuron.
          <year>2013</year>
<volume>80</volume>
<fpage>633</fpage>
<lpage>647</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2013.10.045</pub-id>
<pub-id pub-id-type="pmid">24183016</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rubenstein</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Merzenich</surname>
<given-names>MM</given-names>
</name>
</person-group>
<article-title>Model of autism: increased ratio of excitation/inhibition in key neural systems</article-title>
<source/>Genes. Brain. Behav.
          <year>2003</year>
<volume>2</volume>
<fpage>255</fpage>
<lpage>267</lpage>
<pub-id pub-id-type="doi">10.1034/j.1601-183X.2003.00037.x</pub-id>
<pub-id pub-id-type="pmid">14606691</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gibson</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Bartley</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Hays</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>KM</given-names>
</name>
</person-group>
<article-title>Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome</article-title>
<source/>J. Neurophysiol.
          <year>2008</year>
<volume>100</volume>
<fpage>2615</fpage>
<lpage>2626</lpage>
<pub-id pub-id-type="doi">10.1152/jn.90752.2008</pub-id>
<pub-id pub-id-type="pmid">18784272</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robertson</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Ratai</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Kanwisher</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Reduced GABAergic Action in the Autistic Brain</article-title>
<source/>Curr. Biol.
          <year>2016</year>
<volume>26</volume>
<fpage>80</fpage>
<lpage>85</lpage>
<pub-id pub-id-type="doi">10.1016/j.cub.2015.11.019</pub-id>
<pub-id pub-id-type="pmid">26711497</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<mixed-citation publication-type="other">Bozzi Y., Provenzano G., Casarosa S. Neurobiological bases of autism-epilepsy comorbidity: a focus on excitation/inhibition imbalance. <italic>Eur J Neurosci</italic> (2017) doi:10.1101/cshperspect.a028092.</mixed-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Camp</surname>
<given-names>JG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human cerebral organoids recapitulate gene expression programs of fetal neocortex development</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2015</year>
<volume>112</volume>
<fpage>15672</fpage>
<lpage>15677</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1508055112</pub-id>
<pub-id pub-id-type="pmid">26644564</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Darmanis</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A survey of human brain transcriptome diversity at the single cell level</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2015</year>
<volume>112</volume>
<fpage>7285</fpage>
<lpage>7290</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1507125112</pub-id>
<pub-id pub-id-type="pmid">26060301</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dobin</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title> STAR: ultrafast universal RNA-seq aligner</article-title>
<source/>Bioinformatics.
          <year>2013</year>
<volume>29</volume>
<fpage>15</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id>
<pub-id pub-id-type="pmid">23104886</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data</article-title>
<source/>Bioinformatics.
          <year>2011</year>
<volume>27</volume>
<fpage>2987</fpage>
<lpage>2993</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btr509</pub-id>
<pub-id pub-id-type="pmid">21903627</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Sequence Alignment/Map format and SAMtools</article-title>
<source/>Bioinformatics.
          <year>2009</year>
<volume>25</volume>
<fpage>2078</fpage>
<lpage>2079</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id>
<pub-id pub-id-type="pmid">19505943</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Smyth</surname>
<given-names>GK</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>featureCounts: an efficient general purpose program for assigning sequence reads to genomic features</article-title>
<source/>Bioinformatics.
          <year>2014</year>
<volume>30</volume>
<fpage>923</fpage>
<lpage>930</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btt656</pub-id>
<pub-id pub-id-type="pmid">24227677</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lake</surname>
<given-names>BB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neuronal subtypes and diversity revealed by single-nucleus RNA sequencing of the human brain</article-title>
<source/>Science
          <year>2016</year>
<volume>352</volume>
<fpage>1586</fpage>
<lpage>1590</lpage>
<pub-id pub-id-type="doi">10.1126/science.aaf1204</pub-id>
<pub-id pub-id-type="pmid">27339989</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>LM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>AutismKB: an evidence-based knowledgebase of autism genetics</article-title>
<source/>Nucleic. Acids. Res.
          <year>2012</year>
<volume>40</volume>
<fpage>D1016</fpage>
<lpage>D1022</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkr1145</pub-id>
<pub-id pub-id-type="pmid">22139918</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allen</surname>
<given-names>NC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database</article-title>
<source/>Nat. Genet.
          <year>2008</year>
<volume>40</volume>
<fpage>827</fpage>
<lpage>834</lpage>
<pub-id pub-id-type="doi">10.1038/ng.171</pub-id>
<pub-id pub-id-type="pmid">18583979</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Schizophrenia Working Group of the Psychiatric Genomics C.</collab>
</person-group>
<article-title>Biological insights from 108 schizophrenia-associated genetic loci</article-title>
<source/>Nature.
          <year>2014</year>
<volume>511</volume>
<fpage>421</fpage>
<lpage>427</lpage>
<pub-id pub-id-type="doi">10.1038/nature13595</pub-id>
<pub-id pub-id-type="pmid">25056061</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>SH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>BDgene: a genetic database for bipolar disorder and its overlap with schizophrenia and major depressive disorder</article-title>
<source/>Biol. Psychiatr.
          <year>2013</year>
<volume>74</volume>
<fpage>727</fpage>
<lpage>733</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2013.04.016</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uezu</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of an elaborate complex mediating postsynaptic inhibition</article-title>
<source/>Science
          <year>2016</year>
<volume>353</volume>
<fpage>1123</fpage>
<lpage>1129</lpage>
<pub-id pub-id-type="doi">10.1126/science.aag0821</pub-id>
<pub-id pub-id-type="pmid">27609886</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lango Allen</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Hundreds of variants clustered in genomic loci and biological pathways affect human height</article-title>
<source/>Nature.
          <year>2010</year>
<volume>467</volume>
<fpage>832</fpage>
<lpage>838</lpage>
<pub-id pub-id-type="doi">10.1038/nature09410</pub-id>
<pub-id pub-id-type="pmid">20881960</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voineagu</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Transcriptomic analysis of autistic brain reveals convergent molecular pathology</article-title>
<source/>Nature.
          <year>2011</year>
<volume>474</volume>
<fpage>380</fpage>
<lpage>384</lpage>
<pub-id pub-id-type="doi">10.1038/nature10110</pub-id>
<pub-id pub-id-type="pmid">21614001</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pramparo</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cell cycle networks link gene expression dysregulation, mutation, and brain maldevelopment in autistic toddlers</article-title>
<source/>Mol. Syst. Biol.
          <year>2015</year>
<volume>11</volume>
<fpage>841</fpage>
<pub-id pub-id-type="doi">10.15252/msb.20156108</pub-id>
<pub-id pub-id-type="pmid">26668231</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parikshak</surname>
<given-names>NN</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism</article-title>
<source/>Nature.
          <year>2016</year>
<volume>540</volume>
<fpage>423</fpage>
<lpage>427</lpage>
<pub-id pub-id-type="doi">10.1038/nature20612</pub-id>
<pub-id pub-id-type="pmid">27919067</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disruption of an Evolutionarily Novel Synaptic Expression Pattern in Autism</article-title>
<source/>PLoS Biol.
          <year>2016</year>
<volume>14</volume>
<fpage>e1002558</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pbio.1002558</pub-id>
<pub-id pub-id-type="pmid">27685936</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mariani</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>FOXG1-Dependent Dysregulation of GABA/Glutamate Neuron Differentiation in Autism Spectrum Disorders</article-title>
<source/>Cell
          <year>2015</year>
<volume>162</volume>
<fpage>375</fpage>
<lpage>390</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2015.06.034</pub-id>
<pub-id pub-id-type="pmid">26186191</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<mixed-citation publication-type="other">Marchetto M. C. et al. Altered proliferation and networks in neural cells derived from idiopathic autistic individuals. <italic>Mol Psychiatr</italic><bold>22</bold>, 820–835 (2017).</mixed-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<mixed-citation publication-type="other">Liu X. et al. Idiopathic Autism: Cellular and Molecular Phenotypes in Pluripotent Stem Cell-Derived Neurons. <italic>Mol Neurobiol</italic><bold>54</bold>, 4507–4523 (2017).</mixed-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in neurodevelopment</article-title>
<source/>Mol Autism
          <year>2015</year>
<volume>6</volume>
<fpage>55</fpage>
<pub-id pub-id-type="doi">10.1186/s13229-015-0048-6</pub-id>
<pub-id pub-id-type="pmid">26491539</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in cerebral organoids derived from iPS cells</article-title>
<source/>Mol Autism
          <year>2017</year>
<volume>8</volume>
<fpage>11</fpage>
<pub-id pub-id-type="doi">10.1186/s13229-017-0124-1</pub-id>
<pub-id pub-id-type="pmid">28321286</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nebel</surname>
<given-names>RA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reduced CYFIP1 in Human Neural Progenitors Results in Dysregulation of Schizophrenia and Epilepsy Gene Networks</article-title>
<source/>PLoS. ONE.
          <year>2016</year>
<volume>11</volume>
<fpage>e0148039</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0148039</pub-id>
<pub-id pub-id-type="pmid">26824476</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>ES</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular convergence of neurodevelopmental disorders</article-title>
<source/>Am. J. Hum. Genet.
          <year>2014</year>
<volume>95</volume>
<fpage>490</fpage>
<lpage>508</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2014.09.013</pub-id>
<pub-id pub-id-type="pmid">25307298</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gigek</surname>
<given-names>CO</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A molecular model for neurodevelopmental disorders</article-title>
<source/>Transl Psychiatr
          <year>2015</year>
<volume>5</volume>
<fpage>e565</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2015.56</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Functional impacts of NRXN1 knockdown on neurodevelopment in stem cell models</article-title>
<source/>PLoS. ONE.
          <year>2013</year>
<volume>8</volume>
<fpage>e59685</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0059685</pub-id>
<pub-id pub-id-type="pmid">23536886</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>ZNF804A Transcriptional Networks in Differentiating Neurons Derived from Induced Pluripotent Stem Cells of Human Origin</article-title>
<source/>PLoS. ONE.
          <year>2015</year>
<volume>10</volume>
<fpage>e0124597</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0124597</pub-id>
<pub-id pub-id-type="pmid">25905630</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Wakefield</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Smyth</surname>
<given-names>GK</given-names>
</name>
<name>
<surname>Oshlack</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Gene ontology analysis for RNA-seq: accounting for selection bias</article-title>
<source/>Genome. Biol.
          <year>2010</year>
<volume>11</volume>
<fpage>R14</fpage>
<pub-id pub-id-type="doi">10.1186/gb-2010-11-2-r14</pub-id>
<pub-id pub-id-type="pmid">20132535</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Langfelder</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Horvath</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>WGCNA: an R package for weighted correlation network analysis</article-title>
<source/>BMC. Bioinformatics.
          <year>2008</year>
<volume>9</volume>
<fpage>559</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2105-9-559</pub-id>
<pub-id pub-id-type="pmid">19114008</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Aronow</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Jegga</surname>
<given-names>AG</given-names>
</name>
</person-group>
<article-title>Improved human disease candidate gene prioritization using mouse phenotype</article-title>
<source/>BMC. Bioinformatics.
          <year>2007</year>
<volume>8</volume>
<fpage>392</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2105-8-392</pub-id>
<pub-id pub-id-type="pmid">17939863</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<mixed-citation publication-type="other">Wang P., Zhao D., Lachman H., Zheng D. Enriched expression of genes associated with autism spectrum disorders in human inhibitory neurons. <italic>bioRxiv</italic> 2017. doi: https://doi.org/10.1101/142968</mixed-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iossifov</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The contribution of de novo coding mutations to autism spectrum disorder</article-title>
<source/>Nature.
          <year>2014</year>
<volume>515</volume>
<fpage>216</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="doi">10.1038/nature13908</pub-id>
<pub-id pub-id-type="pmid">25363768</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Forstner</surname>
<given-names>AJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of shared risk loci and pathways for bipolar disorder and schizophrenia</article-title>
<source/>PLoS. ONE.
          <year>2017</year>
<volume>12</volume>
<fpage>e0171595</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0171595</pub-id>
<pub-id pub-id-type="pmid">28166306</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coghlan</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>GABA system dysfunction in autism and related disorders: from synapse to symptoms</article-title>
<source/>Neurosci. Biobehav. Rev.
          <year>2012</year>
<volume>36</volume>
<fpage>2044</fpage>
<lpage>2055</lpage>
<pub-id pub-id-type="doi">10.1016/j.neubiorev.2012.07.005</pub-id>
<pub-id pub-id-type="pmid">22841562</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pizzarelli</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Cherubini</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Alterations of GABAergic signaling in autism spectrum disorders</article-title>
<source/>Neural. Plast.
          <year>2011</year>
<volume>2011</volume>
<fpage>297153</fpage>
<pub-id pub-id-type="doi">10.1155/2011/297153</pub-id>
<pub-id pub-id-type="pmid">21766041</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gogolla</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Common circuit defect of excitatory-inhibitory balance in mouse models of autism</article-title>
<source/>J Neurodev Disord
          <year>2009</year>
<volume>1</volume>
<fpage>172</fpage>
<lpage>181</lpage>
<pub-id pub-id-type="doi">10.1007/s11689-009-9023-x</pub-id>
<pub-id pub-id-type="pmid">20664807</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vattikuti</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chow</surname>
<given-names>CC</given-names>
</name>
</person-group>
<article-title>A computational model for cerebral cortical dysfunction in autism spectrum disorders</article-title>
<source/>Biol. Psychiatr.
          <year>2010</year>
<volume>67</volume>
<fpage>672</fpage>
<lpage>678</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2009.09.008</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benes</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Berretta</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder</article-title>
<source/>Neuropsychopharmacology.
          <year>2001</year>
<volume>25</volume>
<fpage>1</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="doi">10.1016/S0893-133X(01)00225-1</pub-id>
<pub-id pub-id-type="pmid">11377916</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Belforte</surname>
<given-names>JE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes</article-title>
<source/>Nat. Neurosci.
          <year>2010</year>
<volume>13</volume>
<fpage>76</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="doi">10.1038/nn.2447</pub-id>
<pub-id pub-id-type="pmid">19915563</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelsom</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Development and specification of GABAergic cortical interneurons</article-title>
<source/>Cell Biosci
          <year>2013</year>
<volume>3</volume>
<fpage>19</fpage>
<pub-id pub-id-type="doi">10.1186/2045-3701-3-19</pub-id>
<pub-id pub-id-type="pmid">23618463</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Croft</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Reactome pathway knowledgebase</article-title>
<source/>Nucleic. Acids. Res.
          <year>2014</year>
<volume>42</volume>
<fpage>D472</fpage>
<lpage>D477</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkt1102</pub-id>
<pub-id pub-id-type="pmid">24243840</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olivetti</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Noebels</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>Interneuron, interrupted: molecular pathogenesis of ARX mutations and X-linked infantile spasms</article-title>
<source/>Curr. Opin. Neurobiol.
          <year>2012</year>
<volume>22</volume>
<fpage>859</fpage>
<lpage>865</lpage>
<pub-id pub-id-type="doi">10.1016/j.conb.2012.04.006</pub-id>
<pub-id pub-id-type="pmid">22565167</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shoubridge</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fullston</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Gecz</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>ARX spectrum disorders: making inroads into the molecular pathology</article-title>
<source/>Hum. Mutat.
          <year>2010</year>
<volume>31</volume>
<fpage>889</fpage>
<lpage>900</lpage>
<pub-id pub-id-type="doi">10.1002/humu.21288</pub-id>
<pub-id pub-id-type="pmid">20506206</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oakley</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Kalume</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Catterall</surname>
<given-names>WA</given-names>
</name>
</person-group>
<article-title>Insights into pathophysiology and therapy from a mouse model of Dravet syndrome</article-title>
<source/>Epilepsia.
          <year>2011</year>
<volume>52</volume>
<fpage>59</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="doi">10.1111/j.1528-1167.2011.03004.x</pub-id>
<pub-id pub-id-type="pmid">21463282</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lasarge</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Danzer</surname>
<given-names>SC</given-names>
</name>
</person-group>
<article-title>Mechanisms regulating neuronal excitability and seizure development following mTOR pathway hyperactivation</article-title>
<source/>Front Mol Neurosci
          <year>2014</year>
<volume>7</volume>
<fpage>18</fpage>
<pub-id pub-id-type="doi">10.3389/fnmol.2014.00018</pub-id>
<pub-id pub-id-type="pmid">24672426</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crino</surname>
<given-names>PB</given-names>
</name>
</person-group>
<article-title>Evolving neurobiology of tuberous sclerosis complex</article-title>
<source/>Acta. Neuropathol.
          <year>2013</year>
<volume>125</volume>
<fpage>317</fpage>
<lpage>332</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-013-1085-x</pub-id>
<pub-id pub-id-type="pmid">23386324</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nelson</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Valakh</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders</article-title>
<source/>Neuron.
          <year>2015</year>
<volume>87</volume>
<fpage>684</fpage>
<lpage>698</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2015.07.033</pub-id>
<pub-id pub-id-type="pmid">26291155</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dani</surname>
<given-names>VS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2005</year>
<volume>102</volume>
<fpage>12560</fpage>
<lpage>12565</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0506071102</pub-id>
<pub-id pub-id-type="pmid">16116096</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chao</surname>
<given-names>HT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes</article-title>
<source/>Nature.
          <year>2010</year>
<volume>468</volume>
<fpage>263</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="doi">10.1038/nature09582</pub-id>
<pub-id pub-id-type="pmid">21068835</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<mixed-citation publication-type="other">Meng X. <italic>et al</italic>. Manipulations of MeCP2 in glutamatergic neurons highlight their contributions to Rett and other neurological disorders. <italic>eLife</italic><bold>5</bold>, e14199 (2016).</mixed-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<mixed-citation publication-type="other">Ure K. <italic>et al</italic>. Restoration of Mecp2 expression in GABAergic neurons is sufficient to rescue multiple disease features in a mouse model of Rett syndrome. <italic>eLife</italic><bold>5</bold>, e14198 (2016).</mixed-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colantuoni</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Temporal dynamics and genetic control of transcription in the human prefrontal cortex</article-title>
<source/>Nature.
          <year>2011</year>
<volume>478</volume>
<fpage>519</fpage>
<lpage>523</lpage>
<pub-id pub-id-type="doi">10.1038/nature10524</pub-id>
<pub-id pub-id-type="pmid">22031444</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braat</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kooy</surname>
<given-names>RF</given-names>
</name>
</person-group>
<article-title>The GABAA Receptor as a Therapeutic Target for Neurodevelopmental Disorders</article-title>
<source/>Neuron.
          <year>2015</year>
<volume>86</volume>
<fpage>1119</fpage>
<lpage>1130</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2015.03.042</pub-id>
<pub-id pub-id-type="pmid">26050032</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morgan</surname>
<given-names>JT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism</article-title>
<source/>Biol. Psychiatr.
          <year>2010</year>
<volume>68</volume>
<fpage>368</fpage>
<lpage>376</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2010.05.024</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vargas</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Nascimbene</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Krishnan</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zimmerman</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Pardo</surname>
<given-names>CA</given-names>
</name>
</person-group>
<article-title>Neuroglial activation and neuroinflammation in the brain of patients with autism</article-title>
<source/>Ann. Neurol.
          <year>2005</year>
<volume>57</volume>
<fpage>67</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1002/ana.20315</pub-id>
<pub-id pub-id-type="pmid">15546155</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>